Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$11.72 - $26.81 $24,447 - $55,925
-2,086 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$13.49 - $31.53 $28,140 - $65,771
2,086 New
2,086 $31,000

Others Institutions Holding CDAK

# of Institutions
1
Shares Held
238K
Call Options Held
0
Put Options Held
0

About Codiak BioSciences, Inc.


  • Ticker CDAK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,995,200
  • Market Cap $360K
  • Description
  • Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of...
More about CDAK
Track This Portfolio

Track Public Employees Retirement System Of Ohio Portfolio

Follow Public Employees Retirement System Of Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.